Decibel Therapeutics (NASDAQ: DBTX) is owned by 65.02% institutional shareholders, 38.73% Decibel Therapeutics insiders, and 0.00% retail investors. Regeneron Pharmaceuticals Inc is the largest individual Decibel Therapeutics shareholder, owning 2.10M shares representing 8.40% of the company. Regeneron Pharmaceuticals Inc's Decibel Therapeutics shares are currently valued at $8.28M.
If you're new to stock investing, here's how to buy Decibel Therapeutics stock.